Skip to main content
. 2012 Oct 17;2012(10):CD009175. doi: 10.1002/14651858.CD009175.pub2

Deerojanawong 2006.

Clinical features and settings Multicentre study performed at 3 hospitals in Bangkok, Thailand (Queen Sirkit National Insititute of Health, King Chulalongkorn Memorial Hospital, Ramathibodi Hospital)
Clinical features for study inclusion: clinical and radiological diagnosis of community‐acquired pneumonia, defined as new infiltrates or consolidation on chest X‐ray that could not be attributed to other aetiology and the presence of 3 or more of: cough, acute change in quality of sputum, fever or hypothermia (> 38 °C or < 36.1 °C) within the preceding 24 hours, rales or evidence of pulmonary consolidation, leukocytosis, malaise/myalgia or gastrointestinal symptoms
Participants Children aged 2 to 15 years with community‐acquired pneumonia
Children were excluded if they had evidence or history of tuberculosis, nosocomial pneumonia, aspiration pneumonia or bronchiectasis. Children were also excluded if they were HIV‐positive or had been hospitalised within 2 weeks prior to consultation
Number of participants: 257
Number of participants who underwent testing for M. pneumoniae: 245
Male participants: 135, (55.1%)
Number of participants with M. pneumoniae: 36, (14.7%)
Study design Prospective observational cohort study
Target condition and reference standard(s) M. pneumoniae detected using:
  1. serological testing of acute and convalescent blood samples taken 2 to 4 weeks apart (particle agglutination test)

  2. PCR analysis of respiratory secretion samples (throat swabs, sputum or nasopharyngeal aspirate). Presence of current M. pneumoniae infection was defined as a fourfold or greater rise in antibody titres between paired acute and convalescent sera or high antibody titres (>= 1:160) in both serum samples together with the presence of positive PCR for M. pneumoniae in respiratory secretions


Results of single serum samples were excluded from the analysis. The presence of positive PCR for M. pneumoniae in the absence of a positive serologic response was interpreted as possible carriage
Index and comparator tests Symptoms: cough, fever, chill, chest pain, dyspnoea, malaise, myalgia, diarrhea, wheezing
Signs: rales, rhonchi, bronchial breath sounds
Follow‐up Children followed up during admission. Duration between admission and recording of clinical features/initial sample taking was not reported
Notes In total, 199 children (81%) were treated in hospitals and 3 children (1%) required treatment in the intensive care unit
Table of Methodological Quality
Item Authors' judgement Description
Representative spectrum? 
 All tests Yes Inclusion criteria not based on indicators of disease severity. Co‐morbidities in study population: asthma (n = 51), congestive heart failure (n = 7), hepatic disease (n = 1), renal impairment (n = 1)
Acceptable reference standard? 
 All tests Yes In total 36 children met laboratory diagnostic criteria for current M. pneumoniae infection; 24 children were diagnosed by a fourfold or greater increase in antibody titre between acute and convalescent sera and 12 were diagnosed by positive PCR with persistent high antibody titre. 16 children with a 4‐fold or greater increase in antibody titre were also positive by PCR
Acceptable delay between tests? 
 All tests Unclear Timing of nasopharyngeal aspirate and acute blood sample collection in relation to recording of clinical features was not reported
Partial verification avoided? 
 All tests Yes Of the 257 children enrolled in the study with a diagnosis of community‐acquired pneumonia, paired sera could only be obtained from 245 children
Differential verification avoided? 
 All tests Yes All study participants were subjected to the same laboratory tests
Incorporation avoided? 
 All tests Yes The diagnosis of M. pneumoniae was based on laboratory test results only
Reference standard results blinded? 
 All tests Yes Clinical symptoms and signs were recorded during the acute community‐acquired pneumonia illness episode, when the results of convalescent serum samples would not have been available
Index test results blinded? 
 All tests Yes Clear laboratory criteria for laboratory diagnosis of M. pneumoniae were reported
Relevant clinical information? 
 All tests Unclear Baseline data on participant age, sex and co‐morbidity were recorded. However, unclear whether data on duration of illness were collected at the time of study entry
Uninterpretable results reported? 
 All tests Yes Six children had positive PCR results without serological evidence of M. pneumoniae infection. These children were considered to be carriers of M. pneumoniae and were hence not classified as having current M. pneumoniae infection
Withdrawals explained? 
 All tests Yes Explained that they were only able to obtain paired sera from 245/257 children. The 12 children from whom convalescent serum samples could not be obtained were excluded from the study population